HFDCX
Price
$18.29
Change
+$0.04 (+0.22%)
Updated
Dec 26 closing price
VIMAX
Price
$333.23
Change
+$0.02 (+0.01%)
Updated
Dec 26 closing price
Ad is loading...

HFDCX vs VIMAX

Header iconHFDCX vs VIMAX Comparison
Open Charts HFDCX vs VIMAXBanner chart's image
Hartford Schroders US MidCap Opps C
Price$18.29
Change+$0.04 (+0.22%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$333.23
Change+$0.02 (+0.01%)
VolumeN/A
CapitalizationN/A
HFDCX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HFDCX vs. VIMAX commentary
Dec 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFDCX is a Hold and VIMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. HFDCX (1.03B). VIMAX pays higher dividends than HFDCX: VIMAX (1.49) vs HFDCX (0.00). HFDCX was incepted earlier than VIMAX: HFDCX (8 years) vs VIMAX (23 years). HFDCX is a more actively managed with annual turnover of: 34.00 vs. VIMAX (13.00). HFDCX has a lower initial minimum investment than VIMAX: HFDCX (2000) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.54 vs. HFDCX (6.65). VIMAX return over 5 years is better than : 52.73 vs. HFDCX (15.03).
HFDCXVIMAXHFDCX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD6.89715.98143%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B190B1%
Annual Yield % from dividends0.001.49-
Returns for 1 year6.6515.5443%
Returns for 3 years-0.546.21-9%
Returns for 5 years15.0352.7329%
Returns for 10 yearsN/A119.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNT3.490.02
+0.57%
Senstar Technologies Corp
HP30.890.17
+0.55%
Helmerich & Payne
HEI240.560.51
+0.21%
HEICO Corp
SBT4.76N/A
N/A
Sterling Bancorp
ELVN22.71-0.44
-1.90%
Enliven Therapeutics